The side effect profile is well-characterized: nausea, constipation , and gastrointestinal discomfort are the most common issues, typically resolving within the first 4-8 weeks
Combining weight-loss products can increase side effects or interactions, and an outside program may duplicate clinical care or lab costs
Superimpositions of the two tirzepatide- and three peptide 20-bound structures to the three receptors bound by the endogenous ligands (GIP, GLP-1 and GCG) showed that the five peptides all adopt a single continuous helix, with the well-overlapped N terminus penetrating to the TMD core stabilized by conserved interactions, while the C terminus anchors the ECD, ECL1 and ECL2 in a receptor- and ligand-specific manner
According to JRNYS materials, options include semaglutide (the active ingredient in Ozempic and Wegovy), tirzepatide (the active ingredient in Mounjaro and Zepbound), and liraglutide (the active ingredient in Saxenda)